Wading into an acrimonious debate over booster doses, researchers in Israel reported on Wednesday that a third dose of the Pfizer-BioNTech coronavirus vaccine can prevent both infections and severe illness in adults older than 60 for at least 12 days. The study, published in the New England Journal of Medicine,Continue Reading

Federal health officials are poised to take the final steps on Saturday to clear the Moderna and Pfizer-BioNTech coronavirus vaccines for very young children —  the only age group in the United States that does not yet have a vaccine option available. If the two vaccines are cleared, as expected,Continue Reading

An independent panel of experts advising the Food and Drug Administration is scheduled to vote on Tuesday on whether to recommend to the agency that Moderna’s coronavirus vaccine be authorized for children and adolescents ages 6 to 17. The panel’s recommendation is a key step toward authorizing the vaccine forContinue Reading

The White House has outlined the early stages of its plan for making coronavirus vaccines available this month to roughly 18 million children younger than 5, the last group of Americans yet to be eligible for the shots. The Biden administration has made 10 million doses available to states andContinue Reading

Federal regulators said they were suspending use of a monoclonal antibody drug known as sotrovimab to treat high-risk Covid-19 patients in the United States because it was unlikely to be effective against the Omicron subvariant known as BA.2. BA.2 is highly transmissible and is now dominant in the United States,Continue Reading

The American pharmaceutical company Ocugen said on Friday that the Food and Drug Administration had rejected its application seeking emergency authorization for an India-made Covid vaccine for those ages 2 to 18. The vaccine, made by the Indian pharmaceutical company Bharat Biotech, has not yet been tested in the UnitedContinue Reading

With Covid treatments still in short supply in the United States, the Food and Drug Administration on Friday gave emergency authorization to a new monoclonal antibody drug that has been found in the laboratory to be potent against the Omicron variant of the coronavirus. The Biden administration says it willContinue Reading

An expert panel to the Centers for Disease Control and Prevention on Thursday voted to recommend that Covid vaccines other than Johnson & Johnson’s should be preferred, citing increasing evidence that the company’s shots can trigger a rare blood clot disorder now linked to dozens of cases and at leastContinue Reading

As the world reels from the emergence of the Omicron variant of the coronavirus, a panel of advisers to the Food and Drug Administration will meet on Tuesday to discuss an antiviral pill from Merck, the first in a new class of treatments that could work against a wide rangeContinue Reading

The domestic industry’s woes extend beyond the consumer mask market. In recent months, the medical supply giants that serve the country’s large hospital systems have eagerly resumed buying lower cost protective equipment from overseas. The companies, among them McKesson, Henry Schein and Cardinal Health, have been lobbying the Biden administrationContinue Reading